Skip to main content

IMPACTO DE LA MATRIZ EXTRACELULAR SOBRE LA BIOLOGIA CELULAR Y LA REPROGRAMACION METABOLICA DE LA FIBROSIS ORGANICA

PID2022-136703OB-I00

•
Funding agency name Agencia Estatal de Investigación
Funding agency acronym AEI
Program Programa Estatal para Impulsar la Investigación Científico-Técnica y su Transferencia
Subprogram Subprograma Estatal de Generación de Conocimiento
Call Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Call year 2022
State Plan 2021-2023 Plan Estatal de Investigación Científica y Técnica y de Innovación
Beneficiary centre AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC)

Resultados relacionados

Resultados totales (Incluyendo duplicados): 1
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Metabolism and bioenergetics in the pathophysiology of organ fibrosis

  • Miguel, Verónica
  • Alcalde-Estévez, Elena
  • Sirera, Belén
  • Rodríguez-Pascual, Fernando
  • Lamas Peláez, Santiago
Fibrosis is the tissue scarring characterized by excess deposition of extracellular matrix (ECM) proteins, mainly collagens. A fibrotic response can take place in any tissue of the body and is the result of an imbalanced reaction to inflammation and wound healing. Metabolism has emerged as a major driver of fibrotic diseases. While glycolytic shifts appear to be a key metabolic switch in activated stromal ECM-producing cells, several other cell types such as immune cells, whose functions are intricately connected to their metabolic characteristics, form a complex network of pro-fibrotic cellular crosstalk. This review purports to clarify shared and particular cellular responses and mechanisms across organs and etiologies. We discuss the impact of the cell-type specific metabolic reprogramming in fibrotic diseases in both experimental and human pathology settings, providing a rationale for new therapeutic interventions based on metabolism-targeted antifibrotic agents., This work was supported by grants from the Spanish Ministry of Science PID2022-136703OB-I00 and PID2019-104233RB-100/AEI/10.13039/501100011033, Comunidad de Madrid Innoren-CM 2022/BMD-7227 and Fundación Renal “Íñigo Álvarez de Toledo”, all from Spain. The CBMSO receives institutional support from Fundación “Ramón Areces”. VM was supported by a FEBS Long-Term Fellowship. VM and EA hold a Juan de la Cierva-Formación fellowship from the Spanish Ministry of Science and Innovation (FJC2020-043505-I and FJC2021-046602-I, respectively). BS is recipient of a pre-doctoral fellowship of the FPI Program (PRE2020-093831) from the Spanish Research State Agency.